Persist AI

Persist AI is revolutionizing the pharmaceutical industry by significantly accelerating the development of long-lasting drug formulations. Traditionally, it takes pharmaceutical companies approximately five years to create injectable medications for chronic conditions such as cancer and diabetes. Persist AI leverages cutting-edge AI-driven automation to streamline this process, aiming to reduce formulation development time to just two years. This represents a substantial 50% reduction in the time required to bring these critical medications to market, potentially benefiting millions of patients worldwide.